Page 17 - IMO-2-3

Innovative Medicines & Omics MSC exosomes for digestive tumors: Bench to bedside

cancer cells. Sci Rep. 2024;14:17812. doi: 10.1002/jcp.28747

doi: 10.1038/s41598-024-68922-6 45. Xue C, Gao Y, Li X, et al. Mesenchymal stem cells derived
from adipose accelerate the progression of colon cancer by
36. Jin R, Zhang B, Zhang X, et al. Exosomes derived from
human mesenchymal stem cells confer drug resistance in inducing a MT-CAFs phenotype via TRPC3/NF-KB axis.
Stem Cell Res Ther. 2022;13:335.
gastric cancer. Cell Cycle. 2015;14(15):2473-2483.
doi: 10.1186/s13287-022-03017-5
doi: 10.1080/15384101.2015.1005530
46. Qu M, Li J, Hong Z, Jia F, He Y, Yuan L. The role of human
37. Mao J, Liang Z, Zhang B, et al. UBR2 enriched in p53 umbilical cord mesenchymal stem cells-derived exosomal
deficient mouse bone marrow mesenchymal stem cell- microRNA-431- p in survival and prognosis of colorectal
exosome promoted gastric cancer progression via Wnt/β- cancer patients. Mutagenesis. 2022;37:164-171.
catenin pathway. Stem Cells. 2017;35(11):2267-2279.
doi: 10.1093/mutage/geac007
doi: 10.1002/stem.2702
47. Chen HL, Li JJ, Jiang F, Shi WJ, Chang GY. MicroRNA-4461
38. Ji R, Lin J, Gu H, Ma J, Fu M, Zhang X. Gastric cancer derived from bone marrow mesenchymal stem cell
derived mesenchymal stem cells promote the migration of exosomes inhibits tumorigenesis by downregulating COPB2
gastric cancer cells through miR-374a-5p. Cell Death Dis. expression in colorectal cancer. Biosci Biotechnol Biochem.
2022;18:918.
2019;84:338-346.
doi: 10.2174/1574888X18666221124145847
doi: 10.1080/09168451.2019.1677452
39. Ma M, Chen S, Liu Z, et al. miRNA-221 of exosomes 48. Pishavar E, Yazdian-Robati R, Abnous K, et al. Aptamer-
originating from bone marrow mesenchymal stem cells functionalized mesenchymal stem cells-derived exosomes
promotes oncogenic activity in gastric cancer. Onco Targets for targeted delivery of SN38 to colon cancer cells. Iran J
Ther. 2017;10:4161-4171.
Basic Med Sci. 2023;26:388-394.
doi: 10.2147/OTT.S143315 doi: 10.22038/IJBMS.2023.68039.14873
40. Qi J, Zhou Y, Jiao Z, et al. Exosomes derived from human 49. Bagheri E, Abnous K, Farzad SA, Taghdisi SM, Ramezani M,
bone marrow mesenchymal stem cells promote tumor Alibolandi M. Targeted doxorubicin-loaded mesenchymal
growth through hedgehog signaling pathway. Cell Physiol stem cells-derived exosomes as a versatile platform for
Biochem. 2017;42(6):2242-2254. fighting against colorectal cancer. Life Sci. 2020;261:118369.
doi: 10.1159/000479998 doi: 10.1016/j.lfs.2020.118369
41. Mansourabadi AH, Aghamajidi A, Faraji F, et al. 50. Han S, Li G, Jia M, et al. Delivery of anti-miRNA-221 for
Mesenchymal stem cells-derived exosomes inhibit the colorectal carcinoma therapy using modified cord blood
expression of Aquaporin-5 and EGFR in HCT-116 human mesenchymal stem cells-derived exosomes. Front Mol
colorectal carcinoma cell line. BMC Mol Cell Biol. 2022;23:40. Biosci. 2021;8:743013.
doi: 10.1186/s12860-022-00439-0 doi: 10.3389/fmolb.2021.743013
42. Jahangiri B, Khalaj-Kondori M, Asadollahi E, Purrafee 51. Ding Y, Mei W, Zheng Z, et al. Exosomes secreted from
Dizaj L, Sadeghizadeh M. MSC-Derived exosomes suppress human umbilical cord mesenchymal stem cells promote
colorectal cancer cell proliferation and metastasis via miR- pancreatic ductal adenocarcinoma growth by transferring
100/mTOR/miR-143 pathway. Int J Pharm. 2022;627:122214. miR-100-5p. Tissue Cell. 2021;73:101623.
doi: 10.1016/j.ijpharm.2022.122214 doi: 10.1016/j.tice.2021.101623
43. Chen J, Li Z, Yue C, et al. Human umbilical cord 52. Ding Y, Cao F, Sun H, et al. Exosomes derived from human
mesenchymal stem cell-derived exosomes carrying miR- umbilical cord mesenchymal stromal cells deliver exogenous
1827 downregulate SUCNR1 to inhibit macrophage miR-145-5p to inhibit pancreatic ductal adenocarcinoma
M2 polarization and prevent colorectal liver metastasis. progression. Cancer Lett. 2018;442:351-361.
Apoptosis. 2023;28:549-565.
doi: 10.1016/j.canlet.2018.10.039
doi: 10.1007/s10495-022-01798-x
53. Shang S, Wang J, Chen S, et al. Exosomal miRNA-1231 derived
44. Xu Y, Shen L, Li F, Yang J, Wan X, Ouyang M. microRNA- from bone marrow mesenchymal stem cells inhibits the
16-5p-containing exosomes derived from bone marrow- activity of pancreatic cancer. Cancer Med. 2019;8:7728-7740.
derived mesenchymal stem cells inhibit proliferation,
migration, and invasion, while promoting apoptosis of doi: 10.1002/cam4.2633
colorectal cancer cells by downregulating ITGA2. J Cell 54. Sherman MH, Beatty GL. Tumor microenvironment in
Physiol. 2019;234:21380-21394. pancreatic cancer pathogenesis and therapeutic resistance.

Volume 2 Issue 3 (2025) 11 doi: 10.36922/IMO025210025